IP Library Granted Patent US 9,089,393
Granted Patent B2
US 9,089,393 · App. 13/432,624 · Granted Jul 28, 2015

Implants, tools, and methods for treatment of pelvic conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,089,393
App. No.
13/432,624
Granted
Jul 28, 2015
Kind
B2
Abstract

Described are various embodiments of surgical procedures, systems, implants, devices, tools, and methods, useful for treating pelvic conditions in a male or female, the pelvic conditions including incontinence (various forms such as fecal incontinence, stress urinary incontinence, urge incontinence, mixed incontinence, etc.), vaginal prolapse (including various forms such as enterocele, cystocele, rectocele, apical or vault prolapse, uterine descent, etc.), and other conditions caused by muscle and ligament weakness, the devices and tools including devices and tools for anchoring an implant to supportive tissue and adjusting the implant.

Claims (28)

1. A combination comprising a pelvic implant and a suture passer assembly, the combination useful to treat a pelvic condition,

the implant comprising a tissue support portion and two opposing mesh extension portions,

the suture passer assembly comprising a proximal end, a shaft, and a shaft distal end, the shaft distal end comprising a suture passer comprising a set of opposed suture passer jaws and a mesh holder comprising a set of mesh holder jaws different from the suture passer jaws,

wherein the mesh holder jaws are located between the opposed suture passer jaws and are capable of engaging the mesh, pulling the engaged mesh in a proximal direction to a location between the suture passer jaws, forming a length-reducing loop in the mesh, and holding the mesh and formed loop between the suture passer jaws, and

the suture passer is capable of passing a suture through the mesh held between the suture passer jaws in a manner to maintain the formed loop.

2. A combination as recited at claim 1 wherein the implant comprises supportive portions consisting of the central support portion and the two extension portions.

3. A combination as recited at claim 2 wherein the implant comprises a self-fixating tip at an end of each extension portion, the implant having a length to allow the self-fixating tip to be placed at tissue of opposing obturator foramen of a patient, with the central support portion supporting tissue of an anus.

4. A combination as recited at claim 3 further comprising one or more insertion tools capable of engaging one or more of the self-fixating tips, passing the one or more self-fixating tips through a medial incision in the patient, and placing the one or more self-fixating tips at the opposing obturator foramen.

5. A method of treating a pelvic condition, the method comprising

providing an implant comprising a tissue support portion, a first mesh extension portion, and a second mesh extension portion,

providing a suture passer assembly comprising a proximal end, a shaft, and a shaft distal end, the shaft distal end comprising a suture passer comprising a set of suture passer jaws and a mesh holder comprising a set of mesh holder jaws,

wherein the mesh holder jaws are located between the opposed suture passer jaws and are capable of engaging the mesh, pulling the engaged mesh in a proximal direction to a location between the suture passer jaws, forming a length-reducing loop in the mesh, and holding the mesh and formed loop between the suture passer jaws, and

the suture passer is capable of passing a suture through the mesh held between the suture passer jaws in a manner to maintain the formed loop,

placing the implant in a patient to support tissue,

using the suture passer assembly to form a loop in the first extension portion and place a suture at the first extension portion to maintain the loop.

6. A method as recited at claim 5 comprising using the suture passer assembly to place a second suture at the second extension portion, and adjusting a length of the second extension portion by tightening the second suture.

7. A method as recited at claim 6 comprising adjusting the length of the first extension portion and the length of the second extension portion together to prevent supported tissue from being moved in a left or a right direction within the patient.

8. A method as recited at claim 7 wherein the pelvic condition is selected from the group consisting of: fecal incontinence and urinary incontinence.

9. A method as recited at claim 8 for treating urinary incontinence, the method comprising:

creating a medial incision in the patient,

placing the tissue support portion to contact tissue to support the urethra,

placing a distal end of the first extension portion in a tissue path extending toward a first obturator foramen of the patient, and

placing a distal end of the second extension portion in a tissue path extending toward a second obturator foramen of the patient.

10. A method as recited at claim 8 for treating fecal incontinence, the method comprising:

creating a medial incision in the patient,

placing the tissue support portion to contact tissue to support the anus,

placing a distal end of the first extension portion in a tissue path extending toward a first obturator foramen of the patient, and

placing a distal end of the second extension portion in a tissue path extending toward a second obturator foramen of the patient.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043778/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043780/0316 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2012
From: KHAMIS, CHAOUKI A.; ROLL, JESSICA L.; MOOSAI, SHIVA P.
To: AMS RESEARCH CORPORATION
Reel/Frame 028376/0994 →